Enigma Diagnostics Ltd (Enigma), a global leader in molecular diagnostic point-of-care (PoC) infectious disease testing, and Beijing Leadman Biochemistry Co., Ltd. (Beijing Leadman) (SZSE:300289), announced they have signed a joint venture agreement to support the growing...
Tags: point of care solutions, clinical genetics
Show per page
1 of 26 Page
1 2 3 ... Next
Popular tags in SelectScience